Pfizer Will Redeem Debentures
The $150 million of 8.75% convertible debentures due in
2006 will be called at 103.68%. However, each $1,000
principal amount of the 8.75% debentures is convertible into
70.7964 Pfizer shares, worth about $5,000 at current prices.
   Pfizer is a diversified health-care company with $6.95
billion in annual sales.